| scholarly article | Q13442814 |
| P50 | author | Valerie L Sim | Q57578937 |
| P2093 | author name string | Grant Norman | |
| Jody Campeau | |||
| P2860 | cites work | Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis? | Q48292509 |
| Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice. | Q48496803 | ||
| TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. | Q48603223 | ||
| Abnormal synaptic protein expression and cell death in murine scrapie. | Q48605040 | ||
| Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. | Q54498834 | ||
| Bile acid metabolism and signaling in liver disease and therapy | Q57128767 | ||
| [Cytotoxicity of bile acids on cultured cells (author's transl)] | Q71272461 | ||
| Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles | Q71428832 | ||
| Bile acids: regulation of apoptosis by ursodeoxycholic acid | Q24653969 | ||
| Formation of native prions from minimal components in vitro | Q24676353 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Bile Acids in Neurodegenerative Disorders | Q28078549 | ||
| The enzymes, regulation, and genetics of bile acid synthesis | Q28204726 | ||
| Irreversible inhibitors of serine, cysteine, and threonine proteases | Q28217093 | ||
| Efficacy and Specificity of Chenodeoxycholic Acid Therapy for Dissolving Gallstones | Q28243178 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Disruption of the oxysterol 7alpha-hydroxylase gene in mice. | Q33896722 | ||
| Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. | Q34075502 | ||
| In vitro generation of infectious scrapie prions. | Q34413661 | ||
| The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent | Q34481547 | ||
| Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway | Q34520873 | ||
| Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease | Q35184541 | ||
| Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice | Q35231059 | ||
| Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial | Q35730907 | ||
| Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease. | Q35861134 | ||
| Deer Prion Proteins Modulate the Emergence and Adaptation of Chronic Wasting Disease Strains. | Q36334348 | ||
| Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. | Q37064641 | ||
| Therapies for human prion diseases | Q37199225 | ||
| Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis | Q37257418 | ||
| Tauroursodeoxycholic acid reduces ER stress by regulating of Akt-dependent cellular prion protein | Q37526157 | ||
| Bile salts in control of lipid metabolism | Q38794385 | ||
| Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. | Q38973518 | ||
| Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells | Q39426414 | ||
| Bile acids, liver injury, and liver disease | Q39956246 | ||
| Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). | Q40506330 | ||
| Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. | Q41341706 | ||
| Effects of bile salts on the plasma membranes of isolated rat hepatocytes | Q41900837 | ||
| Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. | Q43236433 | ||
| A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. | Q43748609 | ||
| The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. | Q44931390 | ||
| Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres | Q46367797 | ||
| Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose | Q46518646 | ||
| The sequential development of the brain lesion of scrapie in three strains of mice | Q47696105 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| infectious disease | Q18123741 | ||
| P577 | publication date | 2018-08-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | High Dose and Delayed Treatment with Bile Acids Ineffective in RML Prion-Infected Mice | |
| P478 | volume | 62 |
Search more.